Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/1996
08/29/1996WO1996018388A3 Cross-linked microparticles and their use as therapeutic vehicles
08/29/1996WO1996017626A3 Water soluble ubiquinone compositions, prodrugs, and methods relating thereto
08/29/1996WO1996014873A3 COVALENTLY BOUND β-GLUCAN CONJUGATES IN TARGETED DELIVERY
08/29/1996DE19506141A1 Verwendung von Aerogelen in der Pharmazie, in der Kosmetik und im Pflanzenschutz Use of aerogels in the pharmaceutical, cosmetics and phytosanitary
08/29/1996CA2213710A1 Method for topical treatment of scar tissue and related tissue reaction to trauma
08/29/1996CA2213569A1 Use of aerogels in agriculture
08/29/1996CA2213566A1 Pharmaceuticals and assays using enzyme subunits
08/29/1996CA2213511A1 Use of inorganic aerogels in pharmacy
08/29/1996CA2213417A1 Novel cationic lipids and the use thereof
08/28/1996EP0728485A2 Composition for external treatment of the hoof mycosis of the unguiculates, particularly the horse
08/28/1996EP0728479A1 Deacetyl moxisylyte in the treatment of acute urinary retention
08/28/1996EP0728476A1 Liposome composition
08/28/1996EP0728215A1 METHOD OF BINDING MATERIAL TO THE $g(b)-AMYLOID PEPTIDE
08/28/1996EP0728155A1 Water soluble active sulfones of poly(ethylene glycol)
08/28/1996EP0728139A1 Amine-derivatized nucleosides and oligonucleosides
08/28/1996EP0728018A1 Therapy
08/28/1996EP0728012A1 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
08/28/1996EP0727996A1 Fenbendazole formulations
08/28/1996EP0727985A1 Composition and method for treating blood vessel disorders of the skin using vitamin k
08/28/1996EP0727984A1 Controlled release preparation
08/28/1996EP0727982A1 Propylene glycol stearate vesicles
08/28/1996EP0727979A1 Novel composition
08/28/1996EP0727978A1 Topical aromatic releasing compositions
08/28/1996EP0536226B1 The combination of growth hormone and insulin-like growth factor-i enhances growth
08/28/1996EP0476045B1 Bioerodible polymers for drug delivery in bone
08/28/1996EP0313578B1 Novel osteoinductive compositions
08/28/1996CN1129984A Immunoassay for soluble fibrin polymers
08/28/1996CN1129955A A truncated keratinocyte growth factor (KGF) having increased biological activity
08/28/1996CN1129947A Polymeric matrices and their uses in pharmaceutical compositions
08/28/1996CN1129904A Therapeutic preparation for inhalation
08/28/1996CN1129737A Modified protein for gene transfer and process for producing the same
08/27/1996US5550289 N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor
08/27/1996US5550263 X-ray contrast agent
08/27/1996US5550225 Reacting an acid in presence of a base with an alkyl chloroformate to form mixed anhydride, reacting formed anhydride with d-maltose in an organic solvent, evaporating solvent, performing liquid/liquid extraction
08/27/1996US5550213 Inhibitors of urokinase plasminogen activator
08/27/1996US5550188 Polymer conjugates ophthalmic devices comprising collagen-polymer conjugates
08/27/1996US5550187 Mixing biocompatible polymer and sterile dry crosslinking agent, extruding into mold having desired size and shape, allowing to crosslink to form implant
08/27/1996US5550158 Method of treating wrinkles using glucoheptonic acid
08/27/1996US5550154 Topical application
08/27/1996US5550111 Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof
08/27/1996US5549915 Magnetically responsive composition for carrying biologically active substances and methods of production
08/27/1996US5549913 Multilayer matrix systems for the controlled release of active principles
08/27/1996US5549912 Controlled release oxycodone compositions
08/27/1996US5549910 Preparation of liposome and lipid complex compositions
08/27/1996US5549906 Nicotine lozenge and therapeutic method for smoking cessation
08/27/1996US5549888 Acidic mixtures containing salicyclic, retinoic, azelaic, lactic, glycolic or pyruvic acids, water soluble glycol ethers and nonionic surfactants
08/27/1996US5549883 (oligo or poly)peptides
08/27/1996CA2001673C Pharmaceutical composition containing piroxicam
08/27/1996CA1338553C Pharmaceutical granulate containing cellulose product
08/23/1996CA2143136A1 Rub on topical anesthetic
08/22/1996WO1996025666A1 NF-λB ACTIVATION REGULATORY PROTEIN, IλB-BETA
08/22/1996WO1996025508A1 Nucleic acid-containing composition, preparation and use thereof
08/22/1996WO1996025393A1 Amphiphilic compounds with at least two hydrophilic and at least two hydrophobic groups based on dicarboxylic acid diamides
08/22/1996WO1996025384A1 Alk(en)yl dicarboxylic acid bisesters, their use and method for preparing them
08/22/1996WO1996025176A1 Therapeutic inhibitor of vascular smooth muscle cells
08/22/1996WO1996025175A1 ADMINISTRATION OF A CYCLOSPORINE-SPECIFIC MONOCLONAL ANTIBODY THAT CROSS-REACTS WITH HIV-1 p24 GAG TO TREAT HIV INFECTION
08/22/1996WO1996025158A1 Medicinal composition containing azulene derivative and process for producing the same
08/22/1996WO1996025154A1 Transdermal formulation
08/22/1996WO1996025150A1 Redispersible nanoparticulate film matrices with protective overcoats
08/22/1996WO1996025149A1 Solid active agent preparations containing hydroxypropyl cellulose
08/22/1996WO1996025145A1 Bio-erodible ophthalmic shield
08/22/1996WO1996017584A3 Combined preparation for stimulating hair growth and optionally nail growth and skin regeneration and for preventing or combatting hair loss
08/22/1996DE19505960A1 Konjugat zur individuellen Dosierung von Arzneimitteln A conjugate for individual dosing of drugs
08/22/1996DE19505100A1 Alk(en)yldicarbonsäurebisester, deren Verwendung sowie Verfahren zu deren Herstellung Alk (en) yldicarbonsäurebisester, their use and processes for their preparation
08/22/1996CA2212874A1 Transdermal formulation
08/22/1996CA2211674A1 Alk(en)yl dicarboxylic acid bisesters, their use and method for preparing them
08/22/1996CA2211671A1 Solid active ingredient compositions containing hydroxypropylcellulose
08/22/1996CA2211162A1 Nucleic acid-containing composition, preparation and use thereof
08/22/1996CA2210441A1 Nf-.kappa.b activation regulatory protein, i.kappa.b-beta
08/21/1996EP0727438A2 Adducts of PEG and GM-CSF
08/21/1996EP0727437A2 Covalent PEG-protein adducts
08/21/1996EP0727436A1 Monoclonal antibodies against tumor associated antigen, their preparation and use
08/21/1996EP0727435A1 Monoclonal antibodies against tumor associated antigen, their preparation and use
08/21/1996EP0727223A1 Polyamino acid oligonucleotide carrier
08/21/1996EP0727222A1 Method of producing semi-solid preparations containing microparticulate substances
08/21/1996EP0727208A1 Transdermal formulation of a compound having muscarinic activity
08/21/1996EP0727205A2 Thermoplastic coating and binder agent for pharmaceutical forms
08/21/1996EP0726947A1 Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
08/21/1996EP0726920A1 High molecular weight polyesterpolycarbonates and the use thereof for the preparation of bioerosible matrices
08/21/1996EP0726778A1 Oral delivery of chemically modified proteins
08/21/1996EP0726773A1 Method for inhibiting angiogenesis using heparinase
08/21/1996EP0726771A1 Desferrioxamine oral delivery system
08/21/1996EP0726770A1 Sulfamethoxazole-specific immunosuppressive agents
08/21/1996EP0726767A1 Biochemically active agents for chemical catalysis and cell receptor activation
08/21/1996EP0726764A1 Multilamellar liposomal arachidonic acid metabolite formulations
08/21/1996EP0726763A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
08/21/1996EP0726758A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
08/21/1996EP0660723B1 Vp6 encapsulated drug delivery
08/21/1996EP0614457B1 Leukotriene-b 4? derivatives, process for preparing the same and medicaments
08/21/1996EP0521880B1 Contrast medium containing a non-ionic contrast agent and sodium and calcium salts
08/21/1996EP0512002B1 Cell-specific enzyme-conjugates for the release of toxic cyanide from cyanogenic prodrugs at target cells
08/21/1996CN1129400A Use of vitamin E. Tocopheryl derivatives in ophthalmic compositions
08/21/1996CN1032571C Plaster for preventing and curing diarrhea and anorexia for infant and preparation method thereof
08/20/1996US5548064 Colony stimulating factor; oral administering
08/20/1996US5548062 Oligo(or poly)peptide
08/20/1996US5548035 Biodegradable copolymer as drug delivery matrix comprising polyethyleneoxide and aliphatic polyester blocks
08/20/1996US5547988 Topical application to reduce appearance of skin aging
08/20/1996US5547981 Antitumor agents
08/20/1996US5547959 For treatment of the autoimmune disease systemic lupus erythematosus
08/20/1996US5547948 Controlled release of steroids from sugar coatings
1 ... 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 ... 1712